Laurent Audoly is the founder of Parthenon Therapeutics. Parthenon Therapeutics has raised $65M in total funding. Latest round: Series A.
Laurent Audoly is the co-founder of Parthenon Therapeutics, a biotech company focused on developing anti-cancer therapies that target immune exclusion in tumors. He announced the company's launch, coinciding with the closure of a $65 million Series A financing round.
Full founder directory · Investor directory · Company funding database · Fundraising library